Blog
Mark Sorrentino: From Doctor, to Researcher, to Patient
Through his own participation in a medical trial, PRA's own Mark Sorrentino gained new perspective on what being a patient in a clinical trial is…
All Results
Blog
Newsletter
Industry Watch
In this first issue of April, Industry Watch is bringing our readers news of the positive impact a digitized smart surveillance system has had on…
Blog
A Mother’s Influence
Kevin Thornton, Marketing Manager for PRA’s Global Marketing Team, shares his family’s story about their experience of caring for a loved one with…
Newsletter
Industry Watch
In this second week of March, we’re bringing our readers news of what we can expect next from CRISPR gene-editing therapies after scientists in the…
Newsletter
Industry Watch
In this week’s Industry Watch we report on findings from Yale researchers who have discovered an alternative treatment to surgery for skin cancer.…
Blog
Improving Treatment for Rare Cancers
In recognition of World Cancer Day on February 4th, we explore questions around the latest rare cancer research, treatments, and how to improve…
Newsletter
Industry Watch
In this third week of January, we bring our readers research updates on antibiotic resistance, and how in comparison, resistance to vaccines is rare.…
Blog
A PRA Expert’s Experience Treating the First Pediatric Patient to Receive CAR T-Cell Therapy
Emily Whitehead was born on May 2nd of 2005, a perfectly healthy baby. When she reached five, her parents noticed bruising on her legs, bleeding…
Blog
What does the Future Hold for Stomach, Lung, and Testicular Cancer Treatments?
Cancer is a leading cause of death worldwide. Despite the lack of a definitive cure for cancer, there are many types of cancer treatments. A…
Case Study
Leveraging Immuno-Oncology Real World Data to Amend Non-Small Cell Lung Cancer Study Design
Learn more about how PRA worked with a sponsor to create higher enrollment rates and more extensive country selection. Discover how they did this by…